(Q33609814)

28 July 2017

1 reference

title

Molecular detection of minimal residual disease in colorectal and breast cancer (English)

1 reference

28 July 2017

Liefers GJ

1

1 reference

PubMed ID

10231411

28 July 2017

Tollenaar RA

series ordinal

2

1 reference

PubMed ID

10231411

28 July 2017

Cleton-Jansen AM

series ordinal

3

1 reference

28 July 2017

1 May 1999

1 reference

28 July 2017

1 reference

28 July 2017

34

1 reference

28 July 2017

5

1 reference

28 July 2017

385-390

1 reference

Restaging of colorectal cancer based on the identification of lymph node micrometastases through immunoperoxidase staining of CEA and cytokeratins

28 July 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Utilization of polymerase chain reaction technology in the detection of solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Mutations in the p53 gene occur in diverse human tumour types

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Specific detection of carcinoembryonic antigen-expressing tumor cells in bone marrow aspirates by polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

pTNM and residual tumor classifications: problems of assessment and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Analysis of any point mutation in DNA. The amplification refractory mutation system (ARMS)

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Spread of colorectal cancer micrometastases in regional lymph nodes by reverse transcriptase-polymerase chain reactions for carcinoembryonic antigen and cytokeratin 20.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

CEA in tumors of other than colorectal origin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Micrometastases and survival in stage II colorectal cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Illegitimate transcription: its use in the study of inherited disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Meeting highlights: International Consensus Panel on the Treatment of Primary Breast Cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Identification of p53 gene mutations in bladder cancers and urine samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

Identification of ras oncogene mutations in the stool of patients with curable colorectal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2559.1999.00716.X

10.1046/J.1365-2559.1999.00716.X

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference

PubMed ID

10231411